Free Trial

Fractyl Health (GUTS) Competitors

Fractyl Health logo
$2.84
+0.02 (+0.71%)
(As of 11/1/2024 ET)

GUTS vs. AXGN, SIBN, FNA, BFLY, ZIMV, CLPT, TCMD, NNOX, ZJYL, and CVRX

Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include AxoGen (AXGN), SI-BONE (SIBN), Paragon 28 (FNA), Butterfly Network (BFLY), ZimVie (ZIMV), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), Jin Medical International (ZJYL), and CVRx (CVRX). These companies are all part of the "medical equipment" industry.

Fractyl Health vs.

AxoGen (NASDAQ:AXGN) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, community ranking, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

AxoGen received 450 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 72.71% of users gave AxoGen an outperform vote.

CompanyUnderperformOutperform
AxoGenOutperform Votes
453
72.71%
Underperform Votes
170
27.29%
Fractyl HealthOutperform Votes
3
100.00%
Underperform Votes
No Votes

AxoGen presently has a consensus price target of $15.00, indicating a potential upside of 7.53%. Fractyl Health has a consensus price target of $22.00, indicating a potential upside of 674.65%. Given Fractyl Health's higher possible upside, analysts plainly believe Fractyl Health is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AxoGen
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Fractyl Health
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

80.3% of AxoGen shares are owned by institutional investors. 7.0% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

AxoGen has higher revenue and earnings than Fractyl Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AxoGen$159.01M3.85-$21.72M-$0.38-36.71
Fractyl Health$119K1,143.80-$77.09MN/AN/A

Fractyl Health has a net margin of 0.00% compared to AxoGen's net margin of -9.53%. Fractyl Health's return on equity of 0.00% beat AxoGen's return on equity.

Company Net Margins Return on Equity Return on Assets
AxoGen-9.53% -17.30% -8.63%
Fractyl Health N/A N/A N/A

In the previous week, Fractyl Health had 1 more articles in the media than AxoGen. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for AxoGen. AxoGen's average media sentiment score of 0.56 beat Fractyl Health's score of 0.24 indicating that AxoGen is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AxoGen
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fractyl Health
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

AxoGen and Fractyl Health tied by winning 7 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GUTS vs. The Competition

MetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$136.11M$4.41B$5.40B$8.53B
Dividend YieldN/A42.37%5.13%4.14%
P/E RatioN/A38.74115.5615.18
Price / Sales1,143.8065.071,484.3492.77
Price / CashN/A49.1039.6634.07
Price / BookN/A4.264.665.02
Net Income-$77.09M$11.52M$119.06M$225.46M
7 Day Performance19.83%1.04%0.80%0.37%
1 Month Performance22.41%0.92%5.65%3.57%
1 Year PerformanceN/A39.40%36.76%29.44%

Fractyl Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GUTS
Fractyl Health
1.6187 of 5 stars
$2.84
+0.7%
$22.00
+674.6%
N/A$136.11M$119,000.000.00102Gap Up
AXGN
AxoGen
1.0824 of 5 stars
$14.46
+3.6%
$15.00
+3.7%
+286.4%$631.97M$173.48M-38.05426Upcoming Earnings
SIBN
SI-BONE
4.214 of 5 stars
$13.15
+0.3%
$22.67
+72.4%
-21.8%$548.28M$150.71M-13.02350Positive News
FNA
Paragon 28
2.4163 of 5 stars
$5.24
+1.0%
$15.25
+191.0%
-38.0%$437.76M$235.44M-7.59343,000Gap Up
BFLY
Butterfly Network
2.4107 of 5 stars
$1.88
-1.3%
$3.00
+60.0%
+151.5%$398.60M$71.08M-3.68460Earnings Report
News Coverage
Gap Up
ZIMV
ZimVie
2.4593 of 5 stars
$13.94
+1.8%
$18.33
+31.5%
+108.6%$384.33M$457.43M-1.052,600News Coverage
CLPT
ClearPoint Neuro
0.9281 of 5 stars
$12.74
-2.2%
$11.33
-11.0%
+126.9%$351.57M$28.07M-17.94110Upcoming Earnings
Short Interest ↑
News Coverage
TCMD
Tactile Systems Technology
2.5741 of 5 stars
$14.58
+0.8%
$23.00
+57.8%
+25.4%$346.45M$281.54M10.57980Upcoming Earnings
NNOX
Nano-X Imaging
1.1351 of 5 stars
$5.93
-0.8%
$14.00
+136.1%
+13.8%$342.63M$10.13M-5.99190News Coverage
Positive News
ZJYL
Jin Medical International
N/A$2.01
-2.4%
N/A-76.9%$311.55M$20.13M0.00245Gap Up
CVRX
CVRx
1.7178 of 5 stars
$13.91
+29.5%
$14.17
+1.8%
-1.5%$303.04M$44.39M-5.43200Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
High Trading Volume

Related Companies and Tools


This page (NASDAQ:GUTS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners